Prostate Cancer - Results from #24460

Routine transition zone biopsy during active surveillance for prostate cancer rarely provides unique evidence of disease progression - Abstract November 14, 2012

Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies - Abstract November 14, 2012

Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: Is there a correlation? - Abstract November 14, 2012

Baseline functional status may predict decisional regret following robotic prostatectomy - Abstract November 14, 2012

The impact of anatomical radical retropubic prostatectomy on cancer control: The 30-year anniversary - Abstract November 14, 2012

Combined application of information theory on laboratory results with classification and regression tree analysis: Analysis of unnecessary biopsy for prostate cancer - Abstract November 13, 2012

Nasty or nice? Findings from a UK survey to evaluate the impact of the National Institute for Health and Clinical Excellence (NICE) clinical guidelines on the management of prostate cancer - Abstract November 13, 2012

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level - Abstract November 13, 2012

Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer - Abstract November 13, 2012

Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy - Abstract November 13, 2012

Imaging of bone metastases in prostate cancer: An update - Abstract November 13, 2012

Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients - Abstract November 13, 2012

Investigation of optimal prostate biopsy schemes for Chinese patients with different clinical characteristics - Abstract November 13, 2012

Hyperbaric oxygen in the treatment of hemorrhagic radiogenic cystitis after prostate cancer - Abstract November 12, 2012

Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? - Abstract November 12, 2012

Imaging primary prostate cancer with 11C-Choline PET/CT: Relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness - Abstract November 12, 2012

Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy? - Abstract November 12, 2012

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients - Abstract November 12, 2012

Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer - Abstract November 10, 2012

Landmarks in hormonal therapy for prostate cancer - Abstract November 10, 2012

Page 1224 of 1438